2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$238.78+$7.49 (+3.24%)
Price as of Jun 23, 2026 3:27 PM EDT- $556.8BMarket Cap
- 56.67%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$238.78+$7.49 (+3.24%)
JNJ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $231.29 | ||
Change | +$2.90 (+1.27%) | ||
Open | $228.95 | ||
High | $231.45 | ||
Low | $227.50 | ||
Previous Close | $228.39 | ||
Volume | 8,518,349 | ||
30-Day Average Volume | 8,357,595 | ||
1-Week Change | -1.85% | ||
1-Month Change | -0.73% | ||
1-Year Change | 56.67% | ||
3-Year Change | 52.43% | ||
5-Year Change | 62.70% | ||
Fundamentals | |||
Shares Outstanding | 2.4B | ||
Total Assets | $200.9B | ||
Market Cap | $556.8B | ||
Enterprise Value | $590.1B | ||
Period: QTR TTM FY | |||
Revenue | $24.1B | ||
Net Income | $5.2B | ||
Free Cash Flow | $1.5B | ||
EBIT | $6.0B | ||
EBITDA | $8.0B | ||
Net Working Capital | $1.5B | ||
EPS | $2.14 | ||
Enterprise Value/EBITDA | 74 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 7 | ||
P/E | 108 | ||
PEG | 47 | ||
Price/Free Cash Flow | 380 | ||
Price/Operating Cash Flow | 221 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.32% | ||
Trailing Annual Dividend Yield | 2.27% | ||
Ex-Dividend Date | 05/26/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield